Vowst's FDA approval is a boon for the prevention of recurrent Clostridioides difficile infection

被引：1
|
作者：
Anand, Ayush [1 ,11 ]
Shaikh, Nameera Parveen [7 ,11 ]
Aggarwal, Yash [3 ,11 ]
Fatima, Umaima [4 ,11 ]
Chapagain, Sanskriti [2 ,11 ]
Chidurala, Rahul [6 ,11 ]
Vaghela, Jenish [5 ]
Surana, Arihant [8 ]
Parikh, Charmy [9 ]
Patel, Raj H. [10 ]
机构：
[1] BP Koirala Inst Hlth Sci, Dharan 56700, Nepal
[2] Devdaha Med Coll & Res Inst, Rupandehi, Nepal
[3] Govt Inst Med Sci, Greater Noida, India
[4] Shadan Inst Med Sci, Hyderabad, Telangana, India
[5] BJ Med Coll, Ahmadabad, Gujarat, India
[6] Sri Ramachandra Inst Higher Educ & Res, Chennai, Tamil Nadu, India
[7] Batumi Shota Rustaveli State Univ, Batumi, Georgia
[8] St Vincent Hosp, Dept Internal Med, Worcester, MA USA
[9] Carle BroMenn Med Ctr, Dept Internal Med, Normal, IL USA
[10] St Mary Hosp, Dept Internal Med, Langhorne, PA USA
[11] Global Consortium Med Educ & Res, Pune, India
来源：
ANNALS OF MEDICINE AND SURGERY | 2023年 / 85卷 / 12期
关键词：
THERAPY; SOCIETY; SER-109; UPDATE;
D O I：
10.1097/MS9.0000000000001410
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：5852 / 5854
页数：3
相关论文
共 50 条
  • [21] Microbiome therapeutics for the treatment of recurrent Clostridioides difficile infection
    Bloom, Patricia P.
    Young, Vincent B.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2023, 23 (01) : 89 - 101
  • [22] Ursodeoxycholic Acid for the Management of Recurrent Clostridioides difficile Infection
    Perreault, Gabriel
    Baylor, Jessica
    Radin, Arielle
    Javitt, Norman
    Chen, Lea Ann
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S824 - S825
  • [23] Efficacy and Safety of Monoclonal Antibodies Against Clostridioides difficile Toxins for Prevention of Recurrent Clostridioides difficile Infection A Systematic Review and Meta-Analysis
    Akiyama, Shintaro
    Yamada, Akihiro
    Komaki, Yuga
    Komaki, Fukiko
    Micic, Dejan
    Sakuraba, Atsushi
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2021, 55 (01) : 43 - 51
  • [24] Fecal microbiota transplantation for recurrent Clostridioides difficile infection
    Haber, Stacy L.
    Raney, Carrington R. K.
    Larson, Trent L.
    Lau, Jennifer Park
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2019, 76 (13) : 935 - 942
  • [25] Pseudomembranes on colostomy in a patient with recurrent Clostridioides difficile infection
    Ueda, Hideki
    Hase, Ryota
    Sato, Akiyuki
    Hosokawa, Naoto
    IDCASES, 2023, 31
  • [26] SER-109 for Recurrent Clostridioides difficile Infection
    Benech, Nicolas
    Galperine, Tatiana
    Sokol, Harry
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (20): : 1956 - 1957
  • [27] Oral microbiome therapy for recurrent Clostridioides difficile infection
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (03): : 205 - 205
  • [28] Risk Factors Associated with Recurrent Clostridioides difficile Infection
    Negrut, Nicoleta
    Bungau, Simona
    Behl, Tapan
    Khan, Shamim Ahmad
    Vesa, Cosmin Mihai
    Bustea, Cristiana
    Nistor-Cseppento, Delia Carmen
    Rus, Marius
    Pavel, Flavia-Maria
    Tit, Delia Mirela
    HEALTHCARE, 2020, 8 (03)
  • [29] Recurrent Clostridioides difficile infection: treat the microbiome as well!
    Klein, Friederike
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2022, 60 (05): : 729 - 729
  • [30] EFFICACY AND SAFETY OF MONOCLONAL ANTIBODIES AGAINST CLOSTRIDIOIDES DIFFICILE TOXINS FOR PREVENTION OF RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION; A SYSTEMATIC REVIEW AND META-ANALYSIS
    Akiyama, Shintaro
    Yamada, Akihiro
    Komaki, Yuga
    Komaki, Fukiko
    Micic, Dejan
    Sakuraba, Atsushi
    GASTROENTEROLOGY, 2020, 158 (06) : S535 - S535
12345